BMCS 4th Synthesis in Drug Discovery and Development 2024
Event
BMCS 4th Synthesis in Drug Discovery and Development
Dates
Tuesday 4th – Wednesday 5th June, 2024 – a date for your diary!
Place
Virtual (Zoom)
Important links and downloads
X hashtag – #SDDD24
Synopsis
Synthesis is at the heart of drug discovery and development. The industry has increasingly demanded higher quality clinical candidates and has sought to exploit less druggable biological targets. Densely functionalised small molecules with a high degree of synthetic complexity are often the result of these demands. Successful programmes therefore require the application of innovative synthesis in all stages of discovery and development. The medicinal chemist’s toolbox is also enhanced by the introduction of novel bioisosteres, often made available only through the application of new synthetic methods. This symposium aims to celebrate the crucial role of synthesis in the success of drug discovery and development.
Who should attend?
Chemists from industry and academia, including synthetic, medicinal, agroscience, and process chemists.
Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC events, please follow this RSC link.
Registration
Registration will be open shortly. Please keep checking the website for up to date information.
Call for Abstracts
Abstract submission will be open shortly. Please keep checking the website for up to date information.
Exhibition/Sponsor Opportunities
Exhibitor package is priced at £100.00 and includes:
– Name and URL link on BMCS event page
– Company logo included in the electronic handbook and rolling slides at the event
– A4 promotional page in the electronic handbook
Note: no delegate registration is included
Exhibitor plus package is priced at £300.00 and includes:
– Name and URL link on BMCs event page
– Company logo included in the electronic handbook and rolling slides at the event
– A4 promotional page in the electronic handbook
– 3 minute pre-recorded video to be played on loop during the breaks
Note: no delegate registration is included
Confirmed Speakers
Scott Lamont, AstraZeneca
Mimi Hii, Imperial College
Scott Bagley, Pfizer
Organising Committee
Katherine Jones, Charles River (Chair)
Martin Swarbrick, Ryvu Therapeutics (Treasurer)
Andrew Williams, RSC BMCS
Duncan Hay, Vertex
Pradip Songara, Rothamsted Research
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail